The mission of the Drug Designing is to provide a forum for publishing new findings on drug discovery and its related fields. Currently our primary research objective is to encourage and assist the development of better and faster measures of research activity. In cases where we believe we can contribute directly, as opposed to through highlighting the work of others, we are producing our own measures of publishing activity. Our work is mainly of interest to investors, organizations and research individuals in the field of drug discovery. Drug Designing Open Access is a journal dedicated to producing analysis, insight and data relating to questions of importance in understanding how to target the receptor molecular for a drug. Drug Designing journal from OMICS Group are an open Access journal named as Drug Designing Open Access which strives to release issues quarterly and is adamant to publish new findings related to the field of drug design.
Last date updated on September, 2021